135 related articles for article (PubMed ID: 2988252)
1. Lymphocyte and monocyte localization of altered adrenergic receptors, cAMP responses, and cAMP phosphodiesterase in atopic dermatitis. A possible mechanism for abnormal radiosensitive helper T cells in atopic dermatitis.
Cooper KD; Chan SC; Hanifin JM
Acta Derm Venereol Suppl (Stockh); 1985; 114():41-7. PubMed ID: 2988252
[No Abstract] [Full Text] [Related]
2. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness.
Grewe SR; Chan SC; Hanifin JM
J Allergy Clin Immunol; 1982 Dec; 70(6):452-7. PubMed ID: 6128357
[TBL] [Abstract][Full Text] [Related]
3. [Changed phosphodiesterase activity of leukocytes in atopic eczema].
Hanifin JM
Hautarzt; 1987 May; 38(5):258-61. PubMed ID: 3038785
[TBL] [Abstract][Full Text] [Related]
4. Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
Butler JM; Ebertz M; Chan SC; Stevens SR; Sobieszczuk D; Hanifin JM
Acta Derm Venereol Suppl (Stockh); 1985; 114():55-60. PubMed ID: 2408432
[TBL] [Abstract][Full Text] [Related]
5. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis.
Butler JM; Chan SC; Stevens S; Hanifin JM
J Allergy Clin Immunol; 1983 May; 71(5):490-7. PubMed ID: 6188771
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood mononuclear leukocyte cyclic adenosine monophosphate specific phosphodiesterase activity in childhood atopic dermatitis.
Coulson IH; Duncan SN; Holden CA
Br J Dermatol; 1989 May; 120(5):607-12. PubMed ID: 2547417
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.
Cooper KD; Kang K; Chan SC; Hanifin JM
J Invest Dermatol; 1985 Jun; 84(6):477-82. PubMed ID: 3998494
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
Chan SC; Li SH; Hanifin JM
J Invest Dermatol; 1993 May; 100(5):681-4. PubMed ID: 8388009
[TBL] [Abstract][Full Text] [Related]
9. Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis.
Holden CA; Chan SC; Hanifin JM
J Invest Dermatol; 1986 Sep; 87(3):372-6. PubMed ID: 3016107
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis.
Chan SC; Reifsnyder D; Beavo JA; Hanifin JM
J Allergy Clin Immunol; 1993 Jun; 91(6):1179-88. PubMed ID: 8389777
[TBL] [Abstract][Full Text] [Related]
11. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.
Robicsek SA; Blanchard DK; Djeu JY; Krzanowski JJ; Szentivanyi A; Polson JB
Biochem Pharmacol; 1991 Jul; 42(4):869-77. PubMed ID: 1651080
[TBL] [Abstract][Full Text] [Related]
12. Intracellular 3',5'-adenosine cyclic monophosphate level regulates house dust mite-induced interleukin-13 production by T cells from mite-sensitive patients with atopic dermatitis.
Kanda N; Watanabe S
J Invest Dermatol; 2001 Jan; 116(1):3-11. PubMed ID: 11168792
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclic AMP metabolism in the rat erythrocyte during chronic beta-adrenergic stimulation. Evidence for calmodulin-mediated alteration of membrane-bound phosphodiesterase activity.
Clayberger CA; Goodman DB; Rasmussen H
J Membr Biol; 1981 Feb; 58(3):191-201. PubMed ID: 6260952
[TBL] [Abstract][Full Text] [Related]
14. Heterologous desensitization of leukocytes: a possible mechanism of beta adrenergic blockade in atopic dermatitis.
Safko MJ; Chan SC; Cooper KD; Hanifin JM
J Allergy Clin Immunol; 1981 Sep; 68(3):218-25. PubMed ID: 6114971
[TBL] [Abstract][Full Text] [Related]
15. Impaired monocyte cyclic AMP responses and monocyte cytotoxicity in atopic dermatitis.
Herlin T; Kragballe K
Allergy; 1980 Dec; 35(8):647-55. PubMed ID: 6261605
[TBL] [Abstract][Full Text] [Related]
16. Relationship between increased cyclic AMP-phosphodiesterase activity and abnormal adenylyl cyclase regulation in leukocytes from patients with atopic dermatitis.
Hanifin JM; Lloyd R; Okubo K; Guerin LL; Fancher L; Chan SC
J Invest Dermatol; 1992 Jun; 98(6 Suppl):100S-105S. PubMed ID: 1316924
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP metabolism in peripheral blood lymphocytes from patients with Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1389-92. PubMed ID: 6094195
[TBL] [Abstract][Full Text] [Related]
18. Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis.
Räsänen L; Lehto M; Reunala T; Jansen C; Leinikki P
Arch Dermatol Res; 1987; 279(4):215-8. PubMed ID: 2960276
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
Chan SC; Hanifin JM
J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
[TBL] [Abstract][Full Text] [Related]
20. [Cell-mediated immunity in atopic dermatitis].
Stingl G; Hintner H
Hautarzt; 1983 Mar; 34(3):107-13. PubMed ID: 6222015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
